Christopher Kim
Overview
Explore the profile of Christopher Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
2759
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang A, Yang Z, Wang X, Kim C, Chatterjee B
Annu Int Conf IEEE Eng Med Biol Soc
. 2025 Mar;
2024:1-4.
PMID: 40031448
This paper introduces an energy-efficient code-division multiple access (CDMA) architecture for wearable devices for the Internet of Bodies (IoB), which is an emerging data communication framework for connected sensor nodes...
2.
Barberio J, Naimi A, Patzer R, Kim C, Hernandez R, Brookhart M, et al.
Am J Epidemiol
. 2025 Jan;
PMID: 39756369
No abstract available.
3.
4.
Patel R, Fallon B, Brandis A, Chang K, Demarsico A, Kassis K, et al.
J Endovasc Ther
. 2024 Sep;
:15266028241276328.
PMID: 39234958
Objective: There is great variability in the treatment of chronic limb-threatening ischemia, including the practice paradigm, vascular provider specialty, devices utilized, and experience with advanced open and/or endovascular treatments, among...
5.
Ramelli L, Docter S, Kim C, Sheth U, Park S
Orthop J Sports Med
. 2024 Aug;
12(8):23259671241262772.
PMID: 39143983
Background: Approximately 6% of people will report Achilles tendon pain during their lifetime, and one-third of these individuals will have Achilles insertional tendinopathy (AIT). For patients who have failed conservative...
6.
7.
Anderson L, Girguis M, Kim E, Shewale J, Braunlin M, Werther W, et al.
Leuk Lymphoma
. 2024 Jun;
65(10):1482-1492.
PMID: 38932630
Understanding the global epidemiology of AML is critical for assessing therapeutic demand and informing healthcare resource allocation. This study estimated current and future AML incidence in 27 countries, described AML...
8.
Barberio J, Lash T, Nooka A, Naimi A, Patzer R, Kim C
Acta Haematol
. 2024 May;
:1.
PMID: 38735288
Introduction: Most multiple myeloma (MM) patients experience cytopenias, likely driven by both disease and treatment-related factors. Immunomodulatory agents (IMiDs), which form the backbone of most anti-myeloma regimens, are known to...
9.
Schlafly M, Prabhakar A, Popovic K, Schlafly G, Kim C, Murphey T
PNAS Nexus
. 2024 May;
3(2):pgae016.
PMID: 38725525
Despite theoretical benefits of collaborative robots, disappointing outcomes are well documented by clinical studies, spanning rehabilitation, prostheses, and surgery. Cognitive load theory provides a possible explanation for why humans in...
10.
Li S, Li A, Beckman J, Kim C, Granich M, Mondin J, et al.
ESC Heart Fail
. 2024 May;
11(5):2742-2748.
PMID: 38725133
Aims: It is unclear whether activated partial thromboplastin time (aPTT) or anti-Xa is more accurate for monitoring heparin anticoagulation in mechanical circulatory support (MCS) patients. This study investigates the relationship...